Adverum Biotechnologies, Inc

(NASDAQ:ADVM)

Latest On Adverum Biotechnologies, Inc (ADVM):

Date/Time Type Description Signal Details
2023-05-12 05:45 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.29N/A
2023-03-31 16:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03N/A
2022-11-11 05:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.40 misses by $0.06N/A
2022-08-11 22:16 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.44 misses by $0.10N/A
2022-07-08 00:31 ESTNewsAdverum gains 13% to reach three-month high after Truist upgradeN/A
2022-06-10 10:03 ESTNewsAdverum wet AMD candidate ADVM-022 shows long-term benefit after single injectionN/A
2022-05-13 06:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.38 misses by $0.07N/A
2022-04-07 03:30 ESTNewsAdverum gets FDA feedback on mid-stage trial for Wet AMD candidateN/A
2022-03-29 21:15 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.35 misses by $0.01N/A
2022-02-07 17:00 ESTNewsAdverum Biotechnologies names new CMON/A
2022-01-03 15:46 ESTNewsAdverum granted FDA’s Orphan Drug Designation for treatment targeting color blindnessN/A
2021-11-05 00:15 ESTNewsAdverum Biotechnologies EPS misses by $0.01N/A
2021-10-02 05:31 ESTNewsAdverum posts promising two-year data for one-time injection in Wet AMDN/A
2021-10-02 05:31 ESTNewsADVM, SCPS, HX and NUVL among after hours moversN/A
2021-08-05 21:02 ESTNewsAdverum Biotechnologies EPS misses by $0.07N/A
2021-07-23 14:16 ESTNewsAdverum plunges as analysts turn bearish citing setback for diabetic macular edema drugN/A
2021-07-22 18:17 ESTNewsAdverum scraps development plans for ADVM-022 to treat diabetic macular edemaN/A
2021-07-20 17:43 ESTNewsAdverum President/CFO resigns, replacement namedN/A
2021-05-07 02:46 ESTNewsAdverum Biotechnologies EPS beats by $0.09, beats on revenueN/A
2021-05-06 06:34 ESTNewsAdverum Biotechnologies: An Uncertain Path ForwardN/A
2021-05-03 17:04 ESTNewsAdverum Bio presents long-term data from ADVM-022 trial in wet AMDN/A
2021-05-03 17:04 ESTNewsAdverum Biotechnologies: One Adverse Event Too ManyN/A
2021-05-03 17:03 ESTNewsTenet reinstated buy at Goldman Sachs, Adverum downgraded; in today’s healthcare analyst actionN/A
2021-04-30 05:05 ESTNewsAs Adverum plunges 62%, major shareholder calls for board changes (updated)N/A
2021-04-29 06:17 ESTNewsAdverum Biotechnologies provides update on ADVM-022 diabetic macular edema trialN/A
2021-03-26 04:01 ESTNewsAdverum Biotechnologies perks up after insider buyingN/A
2021-03-08 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25 to $24.89.Neutral
2021-03-04 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.25 to $25.Neutral
2021-03-03 21:16 ESTNewsAdverum Biotechnologies, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-03 15:02 ESTEarnings EstimateAn EPS average of -$1.82 is estimated for the 2022 year.Sell
2021-03-03 15:02 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-03 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.88 to $25.25.Neutral
2021-03-02 23:02 ESTFinancialsCompany financials have been released.Neutral
2021-03-02 07:16 ESTNewsAdverum Biotechnologies EPS misses by $0.06N/A
2021-03-02 07:16 ESTNewsAdverum Biotechnologies, Inc's (ADVM) CEO Laurent Fischer on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-19 04:46 ESTNewsAdverum Biotechnologies names new business chiefN/A
2021-02-12 11:02 ESTAnalyst RatingThe Analyst Target Price has increased from $25.22 to $25.88.Buy
2021-02-02 21:02 ESTNewsAdverum highlights preclinical long-term safety data on ADVM-022 IVT gene therapyN/A
2021-01-21 05:17 ESTNewsAdverum jumps 16% after insider transactionsN/A
2021-01-11 00:01 ESTNewsAdverum In Wet AMD And Diabetic Macular Edema: Playing In A Differentiated MarketN/A
2021-01-07 22:16 ESTNewsAdverum to invest $80M in new gene therapy manufacturing facilityN/A
2020-12-29 11:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $26.75 to $25.22.Neutral
2020-12-13 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-16 15:01 ESTNewsAdverum ticks lower on underwhelming data from gene therapy in wet-AMDN/A
2020-11-10 19:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $27 to $26.75.Neutral
2020-11-09 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 23:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.38 to $27.Neutral
2020-11-06 11:02 ESTEarnings EstimateAn EPS average of -$0.36 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 01:16 ESTNewsAdverum Biotechnologies EPS beats by $0.04N/A

About Adverum Biotechnologies, Inc (ADVM):

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

ADVM Quotes by TradingView

See Advanced Chart

General

  • Name Adverum Biotechnologies, Inc
  • Symbol ADVM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 167
  • Fiscal Year EndDecember
  • IPO Date2014-07-31
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.adverum.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3419.85
  • Price/Book (Most Recent Quarter) 2.73
  • Enterprise Value Revenue 3700.64
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.68
  • Next Year EPS Estimate -$2.00
  • Next Quarter EPS Estimate -$0.31
  • Return on Assets -21%
  • Return on Equity -39%
  • Earnings Per Share -$1.05
  • Revenue Per Share $0
  • Gross Profit -73309000
  • Quarterly Earnings Growth -70%
View More

Highlights

  • Market Capitalization 1.01 billion
  • EBITDA -59744000
  • Analyst Target Price $24.89
  • Book Value Per Share $4.45
View More

Share Statistics

  • Shares Outstanding 97.8 million
  • Shares Float 61.93 million
  • % Held by Insiders 75%
  • % Held by Institutions 96.25%
  • Shares Short 10.05 million
  • Shares Short Prior Month 9.46 million
  • Short Ratio 14.75
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.49
  • 52 Week High $26.98
  • 52 Week Low $8.27
  • 50 Day Moving Average 12.45
  • 200 Day Moving Average 12.28
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Adverum Biotechnologies, Inc (ADVM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Adverum Biotechnologies, Inc (ADVM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.39-$0.33-18.51%
2020-09-302020-11-05$N/A-$0.31-$0.3511.43%
2020-06-302020-08-10$N/A-$0.36-$0.29-23.58%
2020-03-312020-05-28$N/A-$0.31-$0.27-14.35%
2019-12-312020-03-12$N/A-$0.29-$0.302.26%
2019-09-302019-11-07$250000-$0.25-$0.265.41%
2019-06-302019-08-08$N/A-$0.23-$0.2713.21%
2019-03-312019-05-08$N/A-$0.23-$0.2714.18%
2018-12-312019-03-06$70000-$0.25-$0.2912.59%
2018-09-302018-11-08$833000-$0.34-$0.30-13.98%
2018-06-302018-08-08$493000-$0.30-$0.312.18%
2018-03-312018-05-09$216000-$0.30-$0.29-3.45%
2017-12-312018-03-06$461000-$0.32-$0.346.79%
2017-09-302017-11-08$463000-$0.32-$0.29-10.34%
2017-06-302017-08-08$463000-$0.27-$0.3316.92%
2017-03-312017-05-09$462000-$0.38-$0.26-46.15%
2016-12-312017-03-06$488000-$0.54-$0.30-78.04%
2016-09-302016-11-08$395000-$0.35-$0.29-19.33%
2016-06-302016-08-09$307000-$1.76-$0.33-441.54%
2016-03-312016-05-06$265000-$0.57-$0.29-96.55%
2015-12-312016-03-03$960000-$0.55-$0.40-36.37%
2015-09-302015-11-09$953000-$0.55-$0.42-30.95%
2015-06-302015-08-13$203000-$0.38-$0.392.56%
2015-03-312015-05-13$203000-$0.38-$0.405%
2014-12-312015-03-05$203000-$0.46-$0.29-58.62%
2014-09-302014-11-12$204000-$0.50-$0.21-138.1%
2014-06-302014-09-11$135000-$2.27

Adverum Biotechnologies, Inc (ADVM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 14.75 million -2.83 million
Income Before Tax N/A N/A N/A -22.91 million -18.93 million
Selling General Administrative N/A N/A N/A 9.04 million 8.28 million
Gross Profit N/A N/A N/A N/A -14.2 million
Ebit N/A N/A N/A -23.19 million -19.65 million
Operating Income N/A N/A N/A -23.79 million -19.65 million
Income Tax Expense 1.11 million N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A 14.2 million
Total Other Income Expense Net N/A N/A N/A 885000 728000
Net Income From Continuing Operations N/A N/A N/A -22.91 million -18.93 million
Net Income Applicable to Common Shares -37.63 million -27.77 million -29.2 million N/A -18.93 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -70.74 million -10.84 million -8.83 million
Change to Liabilities -5.52 million 4.45 million N/A 30000 244000
Total Cash Flow from Investing Activities -132.37 million -88.63 million N/A -19.21 million -15.02 million
Net Borrowings -29000 27000 N/A -28000 -28000
Total Cash Flow from Financial Activities N/A N/A 148.62 million 26.77 million -91000
Change to Operating Activities -149000 1.97 million N/A 2.92 million 3.16 million
Change in Cash N/A N/A 64.27 million -7.27 million -24.64 million
Total Cash from Operating Activities -26.54 million -16.91 million -13.62 million -14.84 million -9.53 million
Depreciation N/A N/A 599000 -1.27 million 915000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 5.71 million 4.58 million N/A 2.4 million 2.27 million
Capital Expenditures N/A N/A 4.21 million 8.37 million 6.19 million
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 44.65 million 47.77 million
Total Stockholder Equity N/A N/A N/A 303.95 million 174.96 million
Other Current Liabilities N/A N/A N/A N/A 2.64 million
Total Assets N/A N/A N/A 348.6 million 222.73 million
Common Stock 10000 10000 8000 8000 7000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -502.54 million -464.9 million -437.14 million -407.94 million -385.03 million
Other Liabilities 1.11 million 136000 101000 N/A 48000
Other Assets 1.03 million 1.02 million 1.02 million 1.02 million 1.01 million
Cash N/A N/A N/A 130.16 million 65.9 million
Total Current Liabilities 20.87 million 16.11 million N/A 16.77 million 19.41 million
Other Stockholder Equity -261000 -605000 -598000 -833000 -725000
Property, Plant & Equipment 47.1 million 46.99 million 47.48 million 47.13 million 45.85 million
Total Current Assets 434.44 million 459.7 million N/A 300.45 million 175.87 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 434.35 million 464.71 million 282.56 million N/A 174.96 million
Short Term Investments N/A N/A N/A N/A 100.14 million
Long Term Debt N/A N/A N/A N/A 100000
Inventory N/A N/A N/A N/A N/A
Accounts Payable 2.81 million 3.03 million N/A N/A 4.1 million

Adverum Biotechnologies, Inc (ADVM) Chart:

Adverum Biotechnologies, Inc (ADVM) News:

Below you will find a list of latest news for Adverum Biotechnologies, Inc (ADVM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Adverum Biotechnologies, Inc (ADVM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1710CALL0 00TRUE00
2024-05-1720.25CALL0 20TRUE00
2024-05-1730.06CALL0 01028.41TRUE00
2024-05-1740CALL0 00TRUE00
2024-05-1750CALL0 0652.34TRUE00
2024-05-1760CALL0 0297.99TRUE00
2024-05-1778.6CALL0 1197.51TRUE00
2024-05-1780CALL0 0176.47TRUE00
2024-05-1791.9CALL0 250182.97TRUE00
2024-05-17101.2CALL0 183166.49TRUE00
2024-05-17110CALL0 0147.89FALSE00
2024-05-17120CALL0 0141.92FALSE00
2024-05-17130.31CALL0 6162.4FALSE00
2024-05-17140.6CALL0 4163.96FALSE00
2024-05-17152.85CALL0 5188.77FALSE00
2024-05-17160.15CALL0 60FALSE00
2024-05-17170CALL0 00FALSE00
2024-05-17181.35CALL0 200FALSE00
2024-05-17190.05CALL0 20FALSE00
2024-05-17200CALL0 00FALSE00
2024-05-17210CALL0 00FALSE00
2024-05-17220CALL0 00FALSE00
2024-05-17230CALL0 00FALSE00
2024-05-17240CALL0 00FALSE00
2024-05-17250.15CALL0 50FALSE00
2024-05-17300CALL0 00FALSE00
2024-05-1710PUT0 00FALSE00
2024-05-1720PUT0 200FALSE00
2024-05-1730PUT0 00FALSE00
2024-05-1740PUT0 00FALSE00
2024-05-1750.09PUT0 30FALSE00
2024-05-1760.11PUT0 450FALSE00
2024-05-1770.15PUT0 510FALSE00
2024-05-1780PUT0 00FALSE00
2024-05-1790.4PUT1 9159.09FALSE0.40
2024-05-17100.63PUT10 5136.47FALSE0.630
2024-05-17111.4PUT0 10137.2TRUE00
2024-05-17120PUT0 0122.5TRUE00
2024-05-17130PUT0 0248.24TRUE00
2024-05-17143.32PUT0 2282.07TRUE00
2024-05-17150PUT0 0296.02TRUE00
2024-05-17160PUT0 0288.89TRUE00
2024-05-17170PUT0 0328.77TRUE00
2024-05-17180PUT0 0149.98TRUE00
2024-05-17190PUT0 0312.82TRUE00
2024-05-17200PUT0 0329.73TRUE00
2024-05-17210PUT0 0345.48TRUE00
2024-05-17220PUT0 0381.09TRUE00
2024-05-17230PUT0 0293.78TRUE00
2024-05-17240PUT0 0337.32TRUE00
2024-05-17250PUT0 0271.2TRUE00
2024-05-17300PUT0 0428.05TRUE00
2024-06-2111.45CALL0 30TRUE00
2024-06-212.50.13CALL30 11490TRUE00
2024-06-2130CALL0 0483.04TRUE00
2024-06-2140.1CALL1 580TRUE00
2024-06-2150.1CALL0 0182.34TRUE00
2024-06-2160CALL0 0204.31TRUE00
2024-06-2170CALL0 0212.64TRUE00
2024-06-217.50.1CALL1 240TRUE00
2024-06-2180CALL0 0143.08TRUE00
2024-06-2192.5CALL0 1123.36TRUE00
2024-06-21101.65CALL0 11117.8TRUE00
2024-06-21110CALL0 0123.66FALSE00
2024-06-21120CALL0 0123.76FALSE00
2024-06-21130.8CALL0 10120.91FALSE00
2024-06-21140.55CALL0 10142.23FALSE00
2024-06-21151.2CALL0 40FALSE00
2024-06-21160CALL0 0140.85FALSE00
2024-06-21170CALL0 0123.52FALSE00
2024-06-21180CALL0 0127.63FALSE00
2024-06-21190CALL0 0143.57FALSE00
2024-06-21200CALL0 0132.01FALSE00
2024-06-21210CALL0 0135.63FALSE00
2024-06-21220CALL0 0138.5FALSE00
2024-06-21230CALL0 00FALSE00
2024-06-21240CALL0 00FALSE00
2024-06-21250CALL0 00FALSE00
2024-06-21300.2CALL0 50FALSE00
2024-06-2110.12PUT3 1500FALSE00
2024-06-212.50.85PUT1 20740FALSE00
2024-06-2130.05PUT0 100FALSE00
2024-06-2140PUT0 00FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-2160PUT0 0140.25FALSE00
2024-06-2170.52PUT0 3137.82FALSE00
2024-06-217.50PUT0 00FALSE00
2024-06-2180.6PUT1 1124.88FALSE0.60
2024-06-2191.05PUT9 4130.89FALSE1.050
2024-06-21101.92PUT0 2132.06FALSE00
2024-06-21110PUT0 0122.16TRUE00
2024-06-21123.4PUT0 3119.19TRUE00
2024-06-21130PUT0 0116.43TRUE00
2024-06-21140PUT0 0139.75TRUE00
2024-06-21150PUT0 0124.3TRUE00
2024-06-21160PUT0 0128.18TRUE00
2024-06-21170PUT0 0151.54TRUE00
2024-06-21180PUT0 0134.8TRUE00
2024-06-21190PUT0 0143.58TRUE00
2024-06-21200PUT0 0134.67TRUE00
2024-06-21219.4PUT0 1153.92TRUE00
2024-06-21220PUT0 0176.83TRUE00
2024-06-21230PUT0 0139.96TRUE00
2024-06-21240PUT0 0179.66TRUE00
2024-06-21250PUT0 0320.6TRUE00
2024-06-21300PUT0 0192.71TRUE00
2024-09-2011.05CALL2 30TRUE00
2024-09-202.50.3CALL14 7400TRUE00
2024-09-2030CALL0 0289.32TRUE00
2024-09-2040.12CALL1 410TRUE00
2024-09-2050.15CALL0 0180.89TRUE00
2024-09-2060CALL0 0128.64TRUE00
2024-09-2070CALL0 0115.88TRUE00
2024-09-207.50.1CALL30 310TRUE00
2024-09-2080CALL0 0103.06TRUE00
2024-09-2093CALL0 6108.68TRUE00
2024-09-20100CALL0 0114.71TRUE00
2024-09-20110CALL0 0111.66FALSE00
2024-09-20123CALL0 1115.78FALSE00
2024-09-20133.3CALL0 33117.16FALSE00
2024-09-20140CALL0 0118.12FALSE00
2024-09-20151.55CALL0 3115.01FALSE00
2024-09-20160CALL0 0114.71FALSE00
2024-09-20170CALL0 0109.41FALSE00
2024-09-20181.11CALL10 10107.51FALSE1.110
2024-09-20190CALL0 0114.66FALSE00
2024-09-20201.2CALL0 16118.63FALSE00
2024-09-20210CALL0 0115.51FALSE00
2024-09-20223CALL0 5117.48FALSE00
2024-09-20230.95CALL0 4119.1FALSE00
2024-09-20240CALL0 0119.14FALSE00
2024-09-20251CALL0 27117.46FALSE00
2024-09-20300.72CALL0 1121.98FALSE00
2024-09-2010.25PUT5 170FALSE00
2024-09-202.51PUT3 210FALSE00
2024-09-2030.35PUT0 440FALSE00
2024-09-2040PUT0 00FALSE00
2024-09-2050PUT0 0129.97FALSE00
2024-09-2060PUT0 0119.27FALSE00
2024-09-2071PUT0 5112.44FALSE00
2024-09-207.50PUT0 00FALSE00
2024-09-2080PUT0 0111.62FALSE00
2024-09-2090PUT0 0113.46FALSE00
2024-09-20100PUT0 0120.85FALSE00
2024-09-20110PUT0 0111.95TRUE00
2024-09-20120PUT0 0108.73TRUE00
2024-09-20130PUT0 0117.47TRUE00
2024-09-20140PUT0 0112.12TRUE00
2024-09-20150PUT0 0117.15TRUE00
2024-09-20160PUT0 0115.28TRUE00
2024-09-20170PUT0 0118.44TRUE00
2024-09-20180PUT0 0120.89TRUE00
2024-09-20190PUT0 0124.8TRUE00
2024-09-20200PUT0 0117.3TRUE00
2024-09-20210PUT0 0117.79TRUE00
2024-09-20220PUT0 0117.64TRUE00
2024-09-20230PUT0 0114.2TRUE00
2024-09-20240PUT0 0162.01TRUE00
2024-09-20250PUT0 0119.42TRUE00
2024-09-20300PUT0 0150.17TRUE00
2024-12-2040CALL0 0103.84TRUE00
2024-12-2050CALL0 0123.99TRUE00
2024-12-2060CALL0 0116.71TRUE00
2024-12-2070CALL0 099.1TRUE00
2024-12-2080CALL0 095.94TRUE00
2024-12-2090CALL0 0113.37TRUE00
2024-12-20100CALL0 0107.38TRUE00
2024-12-20113.18CALL0 1117.11FALSE00
2024-12-20120CALL0 0114.59FALSE00
2024-12-20130CALL0 0118.26FALSE00
2024-12-20140CALL0 0117.93FALSE00
2024-12-20152.84CALL7 0118.88FALSE2.840
2024-12-20162.28CALL0 25115.32FALSE00
2024-12-20170CALL0 0113.94FALSE00
2024-12-20180CALL0 0113.55FALSE00
2024-12-20190CALL0 0113.48FALSE00
2024-12-20201.68CALL0 1112.24FALSE00
2024-12-2040PUT0 0123.48FALSE00
2024-12-2050PUT0 0120.09FALSE00
2024-12-2060PUT0 0116.63FALSE00
2024-12-2070PUT0 0108.73FALSE00
2024-12-2080PUT0 0107.46FALSE00
2024-12-2090PUT0 0113.57FALSE00
2024-12-20100PUT0 0112.75FALSE00
2024-12-20110PUT0 0109.82TRUE00
2024-12-20120PUT0 0113.83TRUE00
2024-12-20130PUT0 0115.07TRUE00
2024-12-20140PUT0 0112.37TRUE00
2024-12-20150PUT0 0116.5TRUE00
2024-12-20160PUT0 0116.94TRUE00
2024-12-20170PUT0 0113.79TRUE00
2024-12-20180PUT0 0113.08TRUE00
2024-12-20190PUT0 0116.51TRUE00
2024-12-20200PUT0 0114.93TRUE00

Latest ADVM Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST800$0.952
Jun 13, 2022 7:58 PM EST100$0.952
Jun 13, 2022 7:59 PM EST13$0.951
Jun 13, 2022 7:59 PM EST8$0.951
Jun 13, 2022 7:59 PM EST33$0.951

Adverum Biotechnologies, Inc (ADVM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/0001193125-20-182655-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000021545719006772/0000215457-19-006772-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000083423720004851/0000834237-20-004851-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419000919/0000902664-19-000919-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419001088/0000902664-19-001088-index.htm
2019-05-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419002558/0000902664-19-002558-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266420000939/0000902664-20-000939-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266420001119/0000902664-20-001119-index.htm
2019-03-21SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359419000276/0001013594-19-000276-index.htm
2019-05-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359419000364/0001013594-19-000364-index.htm
2020-08-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359420000655/0001013594-20-000655-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000103738919000142/0001037389-19-000142-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000103738920000303/0001037389-20-000303-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000117266120000647/0001172661-20-000647-index.htm
2018-03-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312518094349/0001193125-18-094349-index.htm
2018-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312518124872/0001193125-18-124872-index.htm
2018-04-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312518124877/0001193125-18-124877-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518150878/0001193125-18-150878-index.htm
2018-05-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312518157646/0001193125-18-157646-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518181838/0001193125-18-181838-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518194580/0001193125-18-194580-index.htm
2018-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518211393/0001193125-18-211393-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518301082/0001193125-18-301082-index.htm
2018-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518306392/0001193125-18-306392-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519060892/0001193125-19-060892-index.htm
2019-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519067443/0001193125-19-067443-index.htm
2019-03-12S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519071950/0001193125-19-071950-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519117153/0001193125-19-117153-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000119312519126512/0001193125-19-126512-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519135105/0001193125-19-135105-index.htm
2019-06-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519174714/0001193125-19-174714-index.htm
2019-06-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312519174720/0001193125-19-174720-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519208871/0001193125-19-208871-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519210860/0001193125-19-210860-index.htm
2019-08-08S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1501756/000119312519216895/0001193125-19-216895-index.htm
2019-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519216899/0001193125-19-216899-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519240084/0001193125-19-240084-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519243345/0001193125-19-243345-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519314138/0001193125-19-314138-index.htm
2020-02-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520029953/0001193125-20-029953-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520033298/0001193125-20-033298-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520033345/0001193125-20-033345-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520071731/0001193125-20-071731-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520112176/0001193125-20-112176-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520123125/0001193125-20-123125-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312520123159/0001193125-20-123159-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520169353/0001193125-20-169353-index.htm
2020-06-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312520174007/0001193125-20-174007-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/0001193125-20-182655-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520215063/0001193125-20-215063-index.htm
2020-08-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520216586/0001193125-20-216586-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520219223/0001193125-20-219223-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520219248/0001193125-20-219248-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038052/0001209191-18-038052-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038054/0001209191-18-038054-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038055/0001209191-18-038055-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038058/0001209191-18-038058-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038066/0001209191-18-038066-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038086/0001209191-18-038086-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118055834/0001209191-18-055834-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011063/0001209191-19-011063-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011066/0001209191-19-011066-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011069/0001209191-19-011069-index.htm
2019-04-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119022581/0001209191-19-022581-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119022603/0001209191-19-022603-index.htm
2019-04-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119026003/0001209191-19-026003-index.htm
2019-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119026004/0001209191-19-026004-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027386/0001209191-19-027386-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027389/0001209191-19-027389-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027391/0001209191-19-027391-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027395/0001209191-19-027395-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027396/0001209191-19-027396-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027398/0001209191-19-027398-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027832/0001209191-19-027832-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044245/0001209191-19-044245-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044247/0001209191-19-044247-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044249/0001209191-19-044249-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044251/0001209191-19-044251-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044254/0001209191-19-044254-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044256/0001209191-19-044256-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044258/0001209191-19-044258-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044260/0001209191-19-044260-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046306/0001209191-19-046306-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046311/0001209191-19-046311-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046313/0001209191-19-046313-index.htm
2019-10-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054092/0001209191-19-054092-index.htm
2019-11-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054741/0001209191-19-054741-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054742/0001209191-19-054742-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119061950/0001209191-19-061950-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120001014/0001209191-20-001014-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007754/0001209191-20-007754-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007755/0001209191-20-007755-index.htm
2020-02-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007756/0001209191-20-007756-index.htm
2020-02-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007757/0001209191-20-007757-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007758/0001209191-20-007758-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007759/0001209191-20-007759-index.htm
2020-02-144/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009846/0001209191-20-009846-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009848/0001209191-20-009848-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011783/0001209191-20-011783-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011785/0001209191-20-011785-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011787/0001209191-20-011787-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011789/0001209191-20-011789-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120012797/0001209191-20-012797-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120012798/0001209191-20-012798-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120020107/0001209191-20-020107-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2020-04-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120025153/0001209191-20-025153-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120025154/0001209191-20-025154-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120027287/0001209191-20-027287-index.htm
2020-05-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120028067/0001209191-20-028067-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031045/0001209191-20-031045-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037330/0001209191-20-037330-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037335/0001209191-20-037335-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037369/0001209191-20-037369-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038958/0001209191-20-038958-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038959/0001209191-20-038959-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038960/0001209191-20-038960-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038962/0001209191-20-038962-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038963/0001209191-20-038963-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038964/0001209191-20-038964-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038966/0001209191-20-038966-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038967/0001209191-20-038967-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120047622/0001209191-20-047622-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120047624/0001209191-20-047624-index.htm
2018-11-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315218016327/0001493152-18-016327-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315219001941/0001493152-19-001941-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315220002379/0001493152-20-002379-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018012437/0001564590-18-012437-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018020510/0001564590-18-020510-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018028654/0001564590-18-028654-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000156459019006536/0001564590-19-006536-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019017203/0001564590-19-017203-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019030765/0001564590-19-030765-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019041787/0001564590-19-041787-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000156459020010503/0001564590-20-010503-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020007251/0001628280-20-007251-index.htm
2020-05-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020008534/0001628280-20-008534-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020012330/0001628280-20-012330-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/0001628280-20-012332-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020015738/0001628280-20-015738-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020015761/0001628280-20-015761-index.htm
2018-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999718004871/9999999997-18-004871-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999719001422/9999999997-19-001422-index.htm
2020-06-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999720003738/9999999997-20-003738-index.htm

Adverum Biotechnologies, Inc (ADVM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adverum Biotechnologies, Inc (ADVM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 75%
Institutional Ownership: 9625%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-17Peter SoparkarChief Legal OfficerBuy7,692.0013.0099,996.0010,692.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120047624/0001209191-20-047624-index.htm
2020-06-16LEONE D PATTERSONPresidentSell13,171.0024.68325,060.28110,488.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037369/0001209191-20-037369-index.htm
2018-06-15Jennifer C. ChengGeneral CounselBuy11,150.00118,863.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm
2020-03-20LEONE D PATTERSONCEO, President and DirectorSell39,526.0010.17401,908.27123,429.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2020-05-06LEONE D PATTERSONCEO, President and DirectorSell20,000.0020.02400,400.00123,659.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-03-17LEONE D PATTERSONCEO, President and DirectorSell474.0010.024,749.24138,531.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120020107/0001209191-20-020107-index.htm
2020-05-06LEONE D PATTERSONCEO, President and DirectorBuy20,000.003.4468,800.00143,659.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-03-20LEONE D PATTERSONCEO, President and DirectorBuy24,424.003.4484,018.56162,955.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2019-05-06James Paul ScopaDirectorBuy20,000.006.71134,200.0020,000.00https://www.sec.gov/Archives/edgar/data/1501756/000120919119027832/0001209191-19-027832-index.htm
2019-12-23LEONE D PATTERSONCEO, President and DirectorSell40,000.0010.72428,800.00228,496.00https://www.sec.gov/Archives/edgar/data/1501756/000120919119061950/0001209191-19-061950-index.htm
2020-02-12Mehdi GasmiDirectorSell10,000.0015.07150,690.00258,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-02-18Mehdi GasmiDirectorSell5,000.0016.2381,156.00258,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2020-02-18Mehdi GasmiDirectorBuy5,000.004.8024,000.00263,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2018-06-15LEONE D PATTERSONSVP, CFO, Interim Pres and CEOBuy88,496.00268,496.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm
2020-02-12Mehdi GasmiDirectorBuy10,000.004.8048,000.00268,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-05-05Mehdi GasmiDirectorSell10,000.0016.26162,573.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-06Mehdi GasmiDirectorSell25,000.0020.03500,667.50274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-18Mehdi GasmiDirectorSell300.0019.035,709.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-20Mehdi GasmiDirectorSell1,401.0020.0128,029.95274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-05-21Mehdi GasmiDirectorSell3,599.0020.0272,048.02274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-15Mehdi GasmiDirectorSell159.0023.593,751.18274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-17Mehdi GasmiDirectorSell268.0025.016,702.71274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-18Mehdi GasmiDirectorSell11,127.0025.01278,328.55274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-22Mehdi GasmiDirectorSell23,605.0025.06591,616.84274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-07-20Mehdi GasmiDirectorSell5,000.0017.6087,978.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-06-15Mehdi GasmiDirectorSell3,425.0023.0078,786.65274,601.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-17Mehdi GasmiDirectorBuy268.004.801,286.40274,710.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-05-18Mehdi GasmiDirectorSell4,700.0018.1185,124.05274,742.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-20Mehdi GasmiDirectorBuy1,401.004.806,724.80275,843.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-15Mehdi GasmiDirectorSell1,416.0021.9331,047.07278,026.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-05-21Mehdi GasmiDirectorBuy3,599.004.8017,275.20278,041.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-05-18Mehdi GasmiDirectorBuy5,000.004.8024,000.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-07-20Mehdi GasmiDirectorBuy5,000.004.8024,000.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-06-15Mehdi GasmiDirectorSell5,000.0021.01105,042.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-05-05Mehdi GasmiDirectorBuy10,000.004.8048,000.00284,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-06-15Mehdi GasmiDirectorBuy10,000.004.8048,000.00284,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-18Mehdi GasmiDirectorBuy11,127.004.8053,409.60285,569.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-22Mehdi GasmiDirectorBuy23,605.004.80113,304.00298,047.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-05-06Mehdi GasmiDirectorBuy25,000.004.80120,000.00299,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-02-14James Paul ScopaDirectorBuy10,000.0013.75137,500.0030,000.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009848/0001209191-20-009848-index.htm
2020-01-15Mehdi GasmiDirectorBuy88,496.00321,418.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2018-06-15Mehdi GasmiChief Science & Tech OfficerBuy88,496.00387,031.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm
2020-05-04James Paul ScopaDirectorBuy23,334.006.48151,204.3253,334.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120027287/0001209191-20-027287-index.htm
2020-08-17Laurent FischerCEO and DirectorBuy7,692.0013.0099,996.007,692.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120047622/0001209191-20-047622-index.htm